dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Marquez Algaba, Ester |
dc.contributor.author | Pigrau Serrallach, Carles |
dc.contributor.author | Bosch Nicolau, Pau |
dc.contributor.author | Viñado Perez, Maria Belen |
dc.contributor.author | Serra Pladevall, Judit |
dc.contributor.author | Almirante Gragera, Benito |
dc.contributor.author | Burgos Cibrian, Joaquin |
dc.date.accessioned | 2022-06-16T07:40:46Z |
dc.date.available | 2022-06-16T07:40:46Z |
dc.date.issued | 2021-10 |
dc.identifier.citation | Marquez-Algaba E, Pigrau C, Bosch-Nicolau P, Viñado B, Serra-Pladevall J, Almirante B, et al. Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens. Microbiol Spectr. 2021 Oct;9(2):e00534-21. |
dc.identifier.issn | 2165-0497 |
dc.identifier.uri | https://hdl.handle.net/11351/7701 |
dc.description | Prostatitis bacteriana aguda; Resistència als antibiòtics; Recaiguda |
dc.description.sponsorship | The Spanish Network for Research in Infectious Diseases is supported by AGAUR grant 2017 SGR 1055, Generalitat de Catalunya. No other financial support was received for this work. |
dc.language.iso | eng |
dc.publisher | American Society for Microbiology |
dc.relation.ispartofseries | Microbiology Spectrum;9(2) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pròstata - Malalties - Tractament |
dc.subject | Microorganismes - Resistència als medicaments |
dc.subject | Pròstata - Malalties - Recaiguda |
dc.subject.mesh | Prostatitis |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Risk Factors |
dc.subject.mesh | Drug Resistance, Bacterial |
dc.title | Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1128/Spectrum.00534-21 |
dc.subject.decs | prostatitis |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | factores de riesgo |
dc.subject.decs | farmacorresistencia bacteriana |
dc.relation.publishversion | https://doi.org/10.1128/Spectrum.00534-21 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Marquez-Algaba E, Bosch-Nicolau P, Burgos J] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Pigrau C, Almirante B] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Seville, Spain. [Viñado B, Serra-Pladevall J] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34585972 |
dc.identifier.wos | 000728629300068 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |